AMPH
Amphastar Pharmaceuticals Stock Analysis
AI Rating
- Quality8/10
- Growth↓ 1/10
- Value↑ 7/10
AMPH Growth
- Revenue Y/Y↓ -1.65%
- EPS Y/Y↓ -36.17%
- FCF Y/Y↓ -29.66%
AMPH Profitability
- Gross margin ↑ 49.50%
- EPS margin↑ 13.60%
- ROIC 5Y↓ 18.52%
AMPH Risk
- Debt / Equity↓ 0.8
- Debt / FCF↓ 4.0
- Interest coverage↑ 5.9
Amphastar Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.